We are live on ! Find out more
APLS

Apellis Pharmaceuticals
APLS

Delisted

APLS was delisted on the 13th of May, 2026.

Back to rankings

323 hedge funds and large institutions have $5.56B invested in Apellis Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 128 funds opening new positions, 89 increasing their positions, 72 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 2 → 6 (+4)

75% more capital invested

Capital invested by funds: $3.17B → $5.56B (+$2.39B)

62% more first-time investments, than exits

New positions opened: 128 | Existing positions closed: 79

43% more call options, than puts

Call options by funds: $52.1M | Put options by funds: $36.5M

24% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 72

16% more funds holding

Funds holding: 279 → 323 (+44)

9.9% more ownership

Funds ownership: 99.89% → 109.78% (+9.9%)

Holders
323
Holders Change
+44
Holders Change %
+15.77%
% of All Funds
3.95%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
128
Increased
89
Reduced
72
Closed
79
Calls
$52.1M
Puts
$36.5M
Net Calls
+$15.7M
Net Calls Change
-$61.6M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$157M
2
PCM
Pentwater Capital Management
Florida
+$113M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$77.3M
4
HI
HBK Investments
Texas
+$76.5M
5
State Street
State Street
Massachusetts
+$48.1M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$269M
2
PCH
Polar Capital Holdings
United Kingdom
-$93.1M
3
RI
RTW Investments
New York
-$85.8M
4
DTC
Deep Track Capital
Connecticut
-$69.3M
5
SL
Siren LLC
Connecticut
-$64.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
WG
126
Winton Group
United Kingdom
$2.79M -$374K -17,362 -20%
Thrivent Financial for Lutherans
127
Thrivent Financial for Lutherans
Minnesota
$2.75M +$1.47M +68,407 New
Capital Fund Management (CFM)
128
Capital Fund Management (CFM)
France
$2.74M +$1.47M +68,112 New
FIA
129
FNY Investment Advisers
New York
$2.54M +$1.36M +63,092 New
ECM
130
ExodusPoint Capital Management
New York
$2.53M -$2.33M -108,167 -63%
Raymond James Financial
131
Raymond James Financial
Florida
$2.52M -$94.1K -4,366 -7%
Jacobs Levy Equity Management
132
Jacobs Levy Equity Management
New Jersey
$2.48M +$1.33M +61,681 New
BC
133
Burney Company
Virginia
$2.48M +$1.33M +61,578 New
IMC Chicago
134
IMC Chicago
Illinois
$2.38M +$817K +37,908 +178%
GC
135
Guggenheim Capital
Illinois
$2.29M +$434K +20,154 +55%
CM
136
Capula Management
Cayman Islands
$2.26M +$1.21M +56,266 New
OGC
137
One68 Global Capital
New York
$2.23M +$1.19M +55,347 New
VF
138
Virtu Financial
New York
$2.2M +$1.18M +54,785 New
PNC Financial Services Group
139
PNC Financial Services Group
Pennsylvania
$2.19M +$20.4K +948 +2%
PP
140
PDT Partners
New York
$2.17M – – –
VI
141
Versor Investments
New York
$2.06M +$1.1M +51,146 New
SOADOR
142
State of Alaska Department of Revenue
Alaska
$2.03M +$1.09M +50,562 New
HWAM
143
Hennion & Walsh Asset Management
New Jersey
$2.03M -$33.6K -1,559 -3%
EC
144
Elmind Capital
New York
$2.01M – – –
CC
145
CIBRA Capital
United Kingdom
$2.01M +$1.08M +50,000 New
TGA
146
TPG GP A
Texas
$2.01M +$1.08M +50,000 New
Treasurer of the State of North Carolina
147
Treasurer of the State of North Carolina
North Carolina
$1.86M +$21.2K +983 +2%
PFSRSONJ
148
Police & Firemen's Retirement System of New Jersey
New Jersey
$1.85M – – –
LSERS
149
Louisiana State Employees Retirement System
Louisiana
$1.83M +$978K +45,400 New
Russell Investments Group
150
Russell Investments Group
United Kingdom
$1.8M +$749K +34,759 +348%
4 5
6
7 8

APLS Hedge Fund Activity: Q1 2026 in Review

323 of the 8,169 institutional investors tracked by Wall St. Rank reported a position in Apellis Pharmaceuticals (APLS) for Q1 2026, worth a combined $5.56B — up 75% from $3.17B a quarter earlier.

Buyers outnumbered sellers: 128 funds opened new APLS positions and 79 closed out — a net gain of 49 holders — while 89 added to existing stakes and 72 trimmed.

The largest buyer was BlackRock, adding an estimated $157M. The largest seller was Wellington Management Group, cutting an estimated $269M.

  • 323 institutional investors held Apellis Pharmaceuticals (APLS) as of Q1 2026, up from 279 in Q4 2025.
  • Funds reported $5.56B of Apellis Pharmaceuticals stock for Q1 2026, up 75% quarter-over-quarter.
  • 128 funds opened new Apellis Pharmaceuticals positions in Q1 2026 and 79 closed out, a net change of +49 holders.
  • The largest Apellis Pharmaceuticals buyer in Q1 2026 was BlackRock, an estimated $157M added.
  • The largest Apellis Pharmaceuticals seller in Q1 2026 was Wellington Management Group, an estimated $269M sold.

Based on aggregated 13F filings for Q1 2026.